Investigating factors affecting participation in heart failure care interventions
Research Into Factors Determining Participation in Two Interventions Modifying the Care Pathways of Patients With Heart Failure in Eastern Occitanie: PRADO-IC and Telemedicine
University Hospital, Montpellier · NCT05417490
This study looks at how factors affect whether heart failure patients who just left the hospital join two different programs designed to help them get better care at home and avoid going back to the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 700 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier (other) |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT05417490 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with heart failure who have recently been hospitalized. It evaluates two interventions aimed at improving care coordination during the transition from hospital to home: the PRADO program, which provides outpatient medical and nursing follow-up, and a telemedicine initiative for remote monitoring. The study aims to understand the factors influencing patient participation in these interventions and their potential impact on reducing rehospitalizations and mortality rates. By analyzing patient experiences and outcomes, the research seeks to enhance the effectiveness of heart failure management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults hospitalized for heart failure or related conditions who agree to participate.
Not a fit: Patients who are pregnant, breastfeeding, unable to provide consent, or legally detained may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved care pathways for heart failure patients, reducing hospital readmissions and mortality.
How similar studies have performed: Preliminary studies have shown success with similar interventions in reducing rehospitalizations and mortality in heart failure patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient * Patient hospitalized at the time of inclusion for cardiac decompensation, or cause of admission for which heart failure plays a decisive or aggravating role (co-infection, etc.) recognized by the clinician. * Patient agreeing to take part in this research (absence of non-objection) Exclusion Criteria: * Refusal to participate * Pregnant or breastfeeding women, patients unable to give protected adult consent, vulnerable people (art.L.1121-6, L.1121-7, L.1211-8, L.1211-9) * Subject deprived of liberty by judicial or administrative decision
Where this trial is running
Montpellier
- University Hospital, Montpellier — Montpellier, France (RECRUITING)
Study contacts
- Principal investigator: François ROUBILLE, PUPH — UH of Montpellier
- Study coordinator: François ROUBILLE, PUPH
- Email: f-roubille@chu-montpellier.fr
- Phone: 4.67.33.61.82
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, heart failure, transitional care, PRADO, remote monitoring